ENDRA Life Sciences (NDRA) executive Thornton bought 1,500 shares for $5,100 at $3.40
Insider transactions reported
Michael Milos Thornton (executive at ENDRA Life Sciences Inc., NDRA) reported that they bought 1,500 shares for $5,100 at $3.40 on Dec 9, 2022. After these transactions the filing shows 19,139 shares held directly.
- Reporting person
- Thornton Michael Milos
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Dec 9, 2022 | Open-market purchase (P) | Common Stock1 | +1,500 | $3.40 | $5,100 | 19,139 direct |
Holdings before and after
- Common Stock: 17,639 to 19,139 direct
Footnotes from the filing
- 1. On December 9, 2022, the Issuer effected a 1-for-20 reverse stock split (the Reverse Stock Split ) of its outstanding Common Stock. The number of securities reported on this Form 4 has been adjusted to reflect the Reverse Stock Split.
Transaction codes in this filing
- Open-market purchase:
- Code P marks a purchase in the open market or a private deal. The insider paid for these securities.
FAQ
What did Thornton report in this NDRA Form 4?
Michael Milos Thornton (executive at ENDRA Life Sciences Inc., NDRA) reported that they bought 1,500 shares for $5,100 at $3.40 on Dec 9, 2022. After these transactions the filing shows 19,139 shares held directly.
How many NDRA shares does Thornton hold after this filing?
The filing shows 19,139 shares held directly after the reported transactions. Form 4 reports only the positions it lists, so this may not be every holding.
What does transaction code P mean on an SEC Form 4?
Code P marks a purchase in the open market or a private deal. The insider paid for these securities.
Historical context for NDRA
Earlier insider filings at NDRA
- Nov 28, 2022SEC Form 4: Tokman Alexander Y bought $1,700 worth of shares (10,000 units at $0.17), increasing direct ownership by 7% to 162,857 units
- Aug 24, 2022SEC Form 4: Thornton Michael Milos bought $5,400 worth of shares (20,000 units at $0.27), increasing direct ownership by 6% to 352,775 units
- Aug 24, 2022SEC Form 4: Tokman Alexander Y bought $5,200 worth of shares (20,000 units at $0.26), increasing direct ownership by 15% to 152,857 units
- May 31, 2022SEC Form 4: Thornton Michael Milos bought $5,250 worth of shares (25,000 units at $0.21), increasing direct ownership by 8% to 332,775 units
- May 23, 2022SEC Form 4: Thornton Michael Milos bought $5,500 worth of shares (25,000 units at $0.22), increasing direct ownership by 9% to 307,775 units
Keep researching NDRA
- NDRA insider tradesEvery buy and sale reported by ENDRA Life Sciences Inc. officers, directors and large holders.
- What is Form 4?The SEC filing that reports a change in an insider's holdings, such as a purchase, sale, option exercise or grant, generally within two business days.
- Form 4 explainedForm 4 is the SEC filing that discloses when officers, directors and 10% owners buy or sell company stock, due within 2 business days. Learn every key field and code.
- Insider trading trackerThe latest insider buys and sales across every stock.
- NDRA financial statementsRevenue, profit, cash flow and balance sheet from ENDRA Life Sciences Inc.'s SEC filings.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Listed since
- 2017
Follow NDRA and get a push notification the moment its next story breaks.